authors
- Ledermann, JA
- Perren, TJ
- Raja, FA
- Embleton, A
- Rustin, GJS
- Jayson, G
- Kaye, SB
- Swart, AM
- Vaughan, M
- Hirte, Holger
Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- September 2013
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1117 Public Health and Health Services (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- European Journal of Cancer Journal